| Literature DB >> 28265572 |
Zewdu Seyoum1, Alemu Zewdu1, Shimelis Dagnachew1, Basazinew Bogale1.
Abstract
A study was conducted from November 2015 to April 2016 to determine fenbendazole and ivermectin resistance status of intestinal nematodes of cart horses in Gondar, Northwest Ethiopia. Forty-five strongyle infected animals were used for this study. The animals were randomly allocated into three groups (15 horses per group). Group I was treated with fenbendazole and Group II with ivermectin and Group III was left untreated. Faecal samples were collected from each cart horse before and after treatment. Accordingly, the reduction in the mean fecal egg count at fourteen days of treatment for ivermectin and fenbendazole was 97.25% and 79.4%, respectively. It was significantly different in net egg count between treatment and control groups after treatment. From the study, resistance level was determined for fenbendazole and suspected for ivermectin. In addition, a questionnaire survey was also conducted on 90 selected cart owners to assess their perception on anthelmintics. In the survey, the most available drugs in the study area used by the owners were fenbendazole and ivermectin. Most respondents have no knowledge about drug management techniques. Hence, animal health extension services to create awareness regarding anthelmintic management that plays a key role in reducing the anthelmintic resistance parasites.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28265572 PMCID: PMC5318625 DOI: 10.1155/2017/5163968
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Details of anthelmintic drugs used in the FECRT for resistance evaluation.
| Trade name | Generic name | Manufacturer | Dose per kg body weight | Route of administration |
|---|---|---|---|---|
| Rangfebenda® |
| CIPLA LTD. Pharmaceutical Co., India | 7.5 mg/kg | With grain feed |
| Ivervic® | Ivermectin | Shenyang Sunvictor Pharmaceutical Co. Ltd./China | 0.2 mg/kg | Orally |
Pre- and posttreatment fecal egg count, standard deviation, and percent reduction in cart horses.
| Sample size | Treatment group | EPG at D0 mean ± SD | EPG at D14 mean ± SD | Reduction in % | LCL | UCL | Remark |
|---|---|---|---|---|---|---|---|
| 15 | Ivermectin | 260 ± 54.11 | 6.67 ± 25.82a | 97.25 | 78.59 | 99.65 | Suspect |
| 15 | Fenbendazole | 223 ± 59.36 | 50 ± 65.46b | 79.4 | 66.50 | 89.96 | Resistance |
| 15 | Control | 200 ± 53.45 | 243 ± 84.23c | NA | NA | NA |
SD: standard deviation, NA: not applicable, D0: day 0, and D014: day 14. a, b, cStatistically different at P < 0.05.
Figure 1Mean EPG at day 0 and EPG at day 14 with the three experimental groups before and after treatment. EPG D0 = EPG day 0 and EPG D14 = EPG day 14.